Biotech entrepreneur Kim Tan
already had made a name for himself in Britain when he
returned to his
home country of Malaysia in 2003 to pioneer a life-sciences sector there.
Partnering with the investment arm of the Malaysian government, Tan founded SpringHill Biotech Ventures, now known as SpringHill Management Ltd., Malaysia's first biotech venture-capital fund.
Focusing on early stage investments and development capital for start-ups in the field of life sciences and social ventures, SpringHill
laid the foundation for the now thriving biotech landscape in Malaysia.
A fellow of the Royal Society of Medicine, Tan serves as an advisor for a number of companies and government agencies around the world.
He chairs the NCI Cancer Hospital in Malaysia, the West Surrey and North Hands Innovation and Growth Team in the UK, and serves on the board of the Asia Pacific Economic Cooperation (APEC) Life Science Forum.
Dato Kim Tan-Personal History
father emigrated from China before Tan was born.
Arriving in Malaysia with nothing but his
father built a successful company from the ground up.
Tan made the most of the opportunities his father's success opened up for him, eventually earning his PhD in biochemistry, founding several successful companies, and emerging as an influential leader for his field, his country and the developing world.
was conferred the title "Dato" by the Penang State Government in 2006.